» Articles » PMID: 20206382

Phosphatidylserine Immobilization of Lentivirus for Localized Gene Transfer

Overview
Journal Biomaterials
Date 2010 Mar 9
PMID 20206382
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Localized and efficient gene transfer can be promoted by exploiting the interaction between the vector and biomaterial. Regulation of the vector-material interaction was investigated by capitalizing on the binding between lentivirus and phosphatidylserine (PS), a component of the plasma membrane. PS was incorporated into microspheres composed of the copolymers of lactide and glycolide (PLG) using an emulsion process. Increasing the weight ratio of PS to PLG led to a greater incorporation of PS. Lentivirus, but not adenovirus, associated with PS-PLG microspheres, and binding was specific to PS relative to PLG alone or PLG modified with phosphatidylcholine. Immobilized lentivirus produced large numbers of transduced cells, and increased transgene expression relative to virus alone. Microspheres were subsequently formed into porous tissue engineering scaffolds, with retention of lentivirus binding. Lentivirus immobilization resulted in long-term and localized expression within a subcutaneously implanted scaffold. Microspheres were also formed into multiple channel bridges for implantation into the spinal cord. Lentivirus delivery from the bridge produced maximal expression at the implant and a gradient of expression rostrally and caudally. This specific binding of lentiviral vectors to biomaterial scaffolds may provide a versatile tool for numerous applications in regenerative medicine or within model systems that investigate tissue development.

Citing Articles

In situ-formable, dynamic crosslinked poly(ethylene glycol) carrier for localized adeno-associated virus infection and reduced off-target effects.

Kato M, Ishikawa S, Shen Q, Du Z, Katashima T, Naito M Commun Biol. 2023; 6(1):508.

PMID: 37193797 PMC: 10188511. DOI: 10.1038/s42003-023-04851-w.


Microencapsulated Multifunctionalized Graphene Oxide Equipped with Chloroquine for Efficient and Sustained siRNA Delivery.

Imani R, Prakash S, Vali H, Presley J, Faghihi S Biomed Res Int. 2022; 2022:5866361.

PMID: 35469347 PMC: 9034959. DOI: 10.1155/2022/5866361.


Lentiviral Vectors Delivered with Biomaterials as Therapeutics for Spinal Cord Injury.

Shortiss C, Howard L, McMahon S Cells. 2021; 10(8).

PMID: 34440872 PMC: 8394044. DOI: 10.3390/cells10082102.


Injectable, macroporous scaffolds for delivery of therapeutic genes to the injured spinal cord.

Ehsanipour A, Sathialingam M, Rad L, de Rutte J, Bierman R, Liang J APL Bioeng. 2021; 5(1):016104.

PMID: 33728392 PMC: 7946441. DOI: 10.1063/5.0035291.


Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair.

Cucchiarini M, Madry H Nat Rev Rheumatol. 2018; 15(1):18-29.

PMID: 30514957 DOI: 10.1038/s41584-018-0125-2.


References
1.
Bradbury E, Khemani S, Von R, King , Priestley J, McMahon S . NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. Eur J Neurosci. 1999; 11(11):3873-83. DOI: 10.1046/j.1460-9568.1999.00809.x. View

2.
Bondi A, Chieregatti G, Eusebi V, Fulcheri E, Bussolati G . The use of beta-galactosidase as a tracer in immunocytochemistry. Histochemistry. 1982; 76(2):153-8. DOI: 10.1007/BF00501918. View

3.
Carneiro F, Bianconi M, Weissmuller G, Stauffer F, Da Poian A . Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein-lipid interactions. J Virol. 2002; 76(8):3756-64. PMC: 136106. DOI: 10.1128/jvi.76.8.3756-3764.2002. View

4.
Geller H, Fawcett J . Building a bridge: engineering spinal cord repair. Exp Neurol. 2002; 174(2):125-36. DOI: 10.1006/exnr.2002.7865. View

5.
Segura T, Shea L . Surface-tethered DNA complexes for enhanced gene delivery. Bioconjug Chem. 2002; 13(3):621-9. DOI: 10.1021/bc015575f. View